154 related articles for article (PubMed ID: 28743594)
1. Rhamnolipids as epithelial permeability enhancers for macromolecular therapeutics.
Perinelli DR; Vllasaliu D; Bonacucina G; Come B; Pucciarelli S; Ricciutelli M; Cespi M; Itri R; Spinozzi F; Palmieri GF; Casettari L
Eur J Pharm Biopharm; 2017 Oct; 119():419-425. PubMed ID: 28743594
[TBL] [Abstract][Full Text] [Related]
2. A mucoadhesive nanoparticulate system for the simultaneous delivery of macromolecules and permeation enhancers to the intestinal mucosa.
Makhlof A; Werle M; Tozuka Y; Takeuchi H
J Control Release; 2011 Jan; 149(1):81-8. PubMed ID: 20138935
[TBL] [Abstract][Full Text] [Related]
3. A head-to-head Caco-2 assay comparison of the mechanisms of action of the intestinal permeation enhancers: SNAC and sodium caprate (C
Twarog C; Liu K; O'Brien PJ; Dawson KA; Fattal E; Illel B; Brayden DJ
Eur J Pharm Biopharm; 2020 Jul; 152():95-107. PubMed ID: 32387703
[TBL] [Abstract][Full Text] [Related]
4. Melittin as an epithelial permeability enhancer I: investigation of its mechanism of action in Caco-2 monolayers.
Maher S; Feighery L; Brayden DJ; McClean S
Pharm Res; 2007 Jul; 24(7):1336-45. PubMed ID: 17373574
[TBL] [Abstract][Full Text] [Related]
5. Improvement of intestinal absorption of insulin and water-soluble macromolecular compounds by chitosan oligomers in rats.
Gao Y; He L; Katsumi H; Sakane T; Fujita T; Yamamoto A
Int J Pharm; 2008 Jul; 359(1-2):70-8. PubMed ID: 18450395
[TBL] [Abstract][Full Text] [Related]
6. Tight junction modulation by chitosan nanoparticles: comparison with chitosan solution.
Vllasaliu D; Exposito-Harris R; Heras A; Casettari L; Garnett M; Illum L; Stolnik S
Int J Pharm; 2010 Nov; 400(1-2):183-93. PubMed ID: 20727955
[TBL] [Abstract][Full Text] [Related]
7. Permeation enhancement via thiolation: in vitro and ex vivo evaluation of hyaluronic acid-cysteine ethyl ester.
Laffleur F; Psenner J; Suchaoin W
J Pharm Sci; 2015 Jul; 104(7):2153-60. PubMed ID: 25900642
[TBL] [Abstract][Full Text] [Related]
8. Lactose oleate as new biocompatible surfactant for pharmaceutical applications.
Perinelli DR; Lucarini S; Fagioli L; Campana R; Vllasaliu D; Duranti A; Casettari L
Eur J Pharm Biopharm; 2018 Mar; 124():55-62. PubMed ID: 29258912
[TBL] [Abstract][Full Text] [Related]
9. Bioactive self-assembling lipid-like peptides as permeation enhancers for oral drug delivery.
Karavasili C; Spanakis M; Papagiannopoulou D; Vizirianakis IS; Fatouros DG; Koutsopoulos S
J Pharm Sci; 2015 Jul; 104(7):2304-11. PubMed ID: 25994901
[TBL] [Abstract][Full Text] [Related]
10. Thiolated nanocarriers for oral delivery of hydrophilic macromolecular drugs.
Dünnhaupt S; Barthelmes J; Köllner S; Sakloetsakun D; Shahnaz G; Düregger A; Bernkop-Schnürch A
Carbohydr Polym; 2015 Mar; 117():577-584. PubMed ID: 25498673
[TBL] [Abstract][Full Text] [Related]
11. Real-time monitoring of trans-epithelial electrical resistance in cultured intestinal epithelial cells: the barrier protection of water-soluble dietary fiber.
Majima A; Handa O; Naito Y; Suyama Y; Onozawa Y; Higashimura Y; Mizushima K; Morita M; Uehara Y; Horie H; Iida T; Fukui A; Dohi O; Okayama T; Yoshida N; Kamada K; Katada K; Uchiyama K; Ishikawa T; Takagi T; Konishi H; Yasukawa Z; Tokunaga M; Okubo T; Itoh Y
J Dig Dis; 2017 Mar; 18(3):151-159. PubMed ID: 28139083
[TBL] [Abstract][Full Text] [Related]
12. Absorption-promoting effects of chitosan in airway and intestinal cell lines: a comparative study.
Vllasaliu D; Casettari L; Fowler R; Exposito-Harris R; Garnett M; Illum L; Stolnik S
Int J Pharm; 2012 Jul; 430(1-2):151-60. PubMed ID: 22525084
[TBL] [Abstract][Full Text] [Related]
13. Rhamnolipids enhance epithelial permeability in Caco-2 monolayers.
Jiang L; Long X; Meng Q
Int J Pharm; 2013 Mar; 446(1-2):130-5. PubMed ID: 23402975
[TBL] [Abstract][Full Text] [Related]
14. Sodium caprate-induced increases in intestinal permeability and epithelial damage are prevented by misoprostol.
Brayden DJ; Maher S; Bahar B; Walsh E
Eur J Pharm Biopharm; 2015 Aug; 94():194-206. PubMed ID: 26026287
[TBL] [Abstract][Full Text] [Related]
15. Modulation of tight junctions does not predict oral absorption of hydrophilic compounds: use of Caco-2 and Calu-3 cells.
Kamath AV; Morrison RA; Mathias NR; Dando SA; Marino AM; Chong S
Arch Pharm Res; 2007 Aug; 30(8):1002-7. PubMed ID: 17879754
[TBL] [Abstract][Full Text] [Related]
16. The effect of various absorption enhancers on tight junction in the human intestinal Caco-2 cell line.
Yu Q; Wang Z; Li P; Yang Q
Drug Dev Ind Pharm; 2013 Apr; 39(4):587-92. PubMed ID: 22656319
[TBL] [Abstract][Full Text] [Related]
17. Impact of amino acid replacements on in vitro permeation enhancement and cytotoxicity of the intestinal absorption promoter, melittin.
Maher S; Devocelle M; Ryan S; McClean S; Brayden DJ
Int J Pharm; 2010 Mar; 387(1-2):154-60. PubMed ID: 20025949
[TBL] [Abstract][Full Text] [Related]
18. Effect of salt forms and molecular weight of chitosans on in vitro permeability enhancement in intestinal epithelial cells (Caco-2).
Opanasopit P; Aumklad P; Kowapradit J; Ngawhiranpat T; Apirakaramwong A; Rojanarata T; Puttipipatkhachorn S
Pharm Dev Technol; 2007; 12(5):447-55. PubMed ID: 17963144
[TBL] [Abstract][Full Text] [Related]
19. Homoharringtonine increases intestinal epithelial permeability by modulating specific claudin isoforms in Caco-2 cell monolayers.
Watari A; Hashegawa M; Yagi K; Kondoh M
Eur J Pharm Biopharm; 2015 Jan; 89():232-8. PubMed ID: 25513955
[TBL] [Abstract][Full Text] [Related]
20. Surfactants enhance the tight-junction permeability of food allergens in human intestinal epithelial Caco-2 cells.
Mine Y; Zhang JW
Int Arch Allergy Immunol; 2003 Feb; 130(2):135-42. PubMed ID: 12673067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
